Apalutamide API is a non-steroidal androgen receptor antagonist. It works by blocking the androgen receptor from binding to testosterone and other androgens, which can slow the growth and spread of cancer cells that rely on androgens for growth.

Apalutamide API is used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It is also being investigated for the treatment of other types of cancer, such as breast cancer, ovarian cancer, and endometrial cancer.

Apalutamide API is typically administered orally once daily. It is generally well-tolerated, but common side effects can include fatigue, hot flashes, diarrhea, and high blood pressure.

Qingmu Pharm is a leading manufacturer and supplier of apalutamide API. The company produces high-quality apalutamide API that is used to manufacture apalutamide-based medicines around the world.

Here are some of the key details about Qingmu Pharm's apalutamide API:

• Product name:Apalutamide API
• CAS number:956104-40-8
• Molecular formula:C29H34FN3O4S
• Molecular weight:67 g/mol
• Appearance:White to light yellow crystalline powder
• Solubility:Insoluble in water; soluble in DMSO and methanol
• Purity:≥99%

Qingmu Pharm's apalutamide API is manufactured in accordance with the highest quality standards and is compliant with cGMP and ISO standards. The company's apalutamide API is registered with regulatory authorities in over 50 countries around the world.

Qingmu Pharm is a reliable and trustworthy supplier of human APIs. The company offers a wide range of high-quality human APIs at competitive prices. Qingmu Pharm is also committed to providing excellent customer service.